Example: Heart Attack

Clinical Trials on Glycogen Storage Disease

Total 158 results

    • NCT03404856
      Unknown status
      Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
      Conditions: Glycogen Storage Disease, Type 14
    • NCT03871673
      Active, not recruiting
      The Use of Uncooked Sweet Polvilho to Treat Hepatic Glycogen Storage Diseases
      Conditions: Glycogen Storage Disease Type I
    • NCT03665636
      Recruiting
      Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I
      Conditions: Glycogen Storage Disease Type I
    • NCT02057731
      Completed
      Study of Glycogen Storage Disease Expression in Carriers
      Conditions: Glycogen Storage Disease
    • NCT02432768
      Completed
      The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)
      Conditions: Glycogen Storage Disease Type V
    • NCT04574830
      Recruiting
      Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
      Conditions: Glycogen Storage Disease Type III
    • NCT04311307
      Recruiting
      Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia
      Conditions: Glycogen Storage Disease Type IA
    • NCT02683512
      Recruiting
      Glycogen Storage Disease Type IV Database
      Conditions: Glycogen Storage Disease Type IV
    • NCT02338817
      Terminated
      Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population
      Conditions: Glycogen Storage Disease
    • NCT00001342
      Completed
      Study of Glycogen Storage Disease and Associated Disorders
      Conditions: Glycogen Storage Disease
    • NCT01961076
      Completed
      Overnight Feeding Study in Glycogen Storage Disease Type 1
      Conditions: Glycogen Storage Disease Type 1 (GSD 1)
    • NCT04454216
      Recruiting
      GSD IX Natural History Study
      Conditions: Glycogen Storage Disease
    • NCT03970278
      Enrolling by invitation
      Long-Term Follow-up to Evaluate the Safety and Efficacy of Adeno Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Glucose-6-Phosphatase (G6Pase) in Adults With Glycogen Storage Disease Type Ia (GSDIa)
      Conditions: Glycogen Storage Disease Type IA; Von Gierke's Disease (GSD Type Ia)
    • NCT02318966
      Active, not recruiting
      Glycosade v UCCS in the Dietary Management of Hepatic GSD
      Conditions: Glycogen Storage Disease
    • NCT03011203
      Completed
      Acute Nutritional Ketosis in GSD IIIa
      Conditions: Glycogen Storage Disease IIIA
    • NCT03844022
      Recruiting
      MRI in McArdle Disease (GSDV)
      Conditions: Glycogen Storage Disease Type V
    • NCT04708015
      Enrolling by invitation
      Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa
      Conditions: Glycogen Storage Disease Type IA
    • NCT02919631
      Unknown status
      Triheptanoin in Mc Ardle
      Conditions: Glycogen Storage Disease Type V
    • NCT01854242
      Completed
      Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
      Conditions: Inflammatory Bowel Disease; Glycogen Storage Disease Type Ia
    • NCT02054832
      Completed
      Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch
      Conditions: Glycogen Storage Disease Type IA; Glycogen Storage Disease Type IB; Glycogen Storage Disease Type III; Glycogen Storage Disease Type 0
    • NCT04138251
      Recruiting
      Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency
      Conditions: Glycogen Storage Disease Type I; Glucose 6 Phosphatase Deficiency
    • NCT04292938
      Recruiting
      McArdle Disease Treatment by Ketogenic Diet
      Conditions: Glycogen Storage Disease
    • NCT00051935
      Completed
      A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II
      Conditions: Glycogen Storage Disease Type II; Pompe Disease; Acid Maltase Deficiency Disease; Glycogenosis 2
    • NCT03255213
      Recruiting
      Lingual Muscle Training in Late-Onset Pompe Disease (LOPD)
      Conditions: Glycogen Storage Disease
    • NCT03112889
      Completed
      Sodium Valproate for GSDV
      Conditions: Glycogen Storage Disease Type V; McArdle Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations